CAPTRUST Financial Advisors
STLN

CAPTRUST Financial Advisors’s Starling Oncology STLN Stock Holding History

CAPTRUST Financial Advisors’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,829
Closed -$157K – 4907
2021
Q3 		$157K Hold
15,829
– – ﹤0.01% 1734
2021
Q2 		$157K Sell
15,829
-767
-5% -$7.72K ﹤0.01% 1690
2021
Q1 		$165K Sell
16,596
-2,752
-14% -$29.3K ﹤0.01% 1612
2020
Q4 		$209K Buy
+19,348
New +$199K ﹤0.01% 1165

Other funds holding STLN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

CAPTRUST Financial Advisors's STLN Position: Q4 2021 in Review

CAPTRUST Financial Advisors sold out of Starling Oncology (STLN) in Q4 2021, closing a stake of 15,829 shares — an estimated $157K sold.

CAPTRUST Financial Advisors first reported a position in STLN in Q4 2020 and held it in 4 quarters. The position peaked at $209K in Q4 2020. 21 funds tracked by Wall St. Rank hold STLN as of Q4 2021.

  • CAPTRUST Financial Advisors reported no remaining Starling Oncology position as of Q4 2021 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 15,829 Starling Oncology shares in Q4 2021, an estimated $157K.
  • CAPTRUST Financial Advisors first reported a position in Starling Oncology in Q4 2020 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's Starling Oncology position peaked at $209K in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Starling Oncology as of Q4 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.